Global Non-Invasive Prenatal Testing Kit Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 23-Nov-2022
No. of pages: 100
Inquire Before Buying

Noninvasive prenatal testing (NIPT) is a method to assess the risk that the fetus will be born with certain genetic abnormalities.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Non-Invasive Prenatal Testing Kit estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Non-Invasive Prenatal Testing Kit is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Non-Invasive Prenatal Testing Kit is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Non-Invasive Prenatal Testing Kit is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Non-Invasive Prenatal Testing Kit include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Non-Invasive Prenatal Testing Kit companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Non-Invasive Prenatal Testing Kit market. Further, it explains the major drivers and regional dynamics of the global Non-Invasive Prenatal Testing Kit market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Sequenom

- Roche

- Natera

- LabCorp

- BGI Genomics

- Quest Diagnostics

- Illumina

- Berry Genomics

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Non-Invasive Prenatal Testing Kit Segment by Type

- High & Average Risk

- Low Risk

Non-Invasive Prenatal Testing Kit Segment by Application

- 0-12 weeks

- 13-24 weeks

- 25-36 weeks

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Non-Invasive Prenatal Testing Kit market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Non-Invasive Prenatal Testing Kit market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Non-Invasive Prenatal Testing Kit, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-Invasive Prenatal Testing Kit, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Invasive Prenatal Testing Kit revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Non-Invasive Prenatal Testing Kit market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Non-Invasive Prenatal Testing Kit revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc.

Global Non-Invasive Prenatal Testing Kit Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Invasive Prenatal Testing Kit Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 High & Average Risk
1.2.3 Low Risk
1.3 Market by Application
1.3.1 Global Non-Invasive Prenatal Testing Kit Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 0-12 weeks
1.3.3 13-24 weeks
1.3.4 25-36 weeks
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Non-Invasive Prenatal Testing Kit Market Size (2017-2028)
2.2 Non-Invasive Prenatal Testing Kit Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Non-Invasive Prenatal Testing Kit Market Size by Region (2017-2022)
2.4 Global Non-Invasive Prenatal Testing Kit Market Size Forecast by Region (2023-2028)
2.5 Global Top Non-Invasive Prenatal Testing Kit Countries Ranking by Market Size
3 Non-Invasive Prenatal Testing Kit Competitive by Company
3.1 Global Non-Invasive Prenatal Testing Kit Revenue by Players
3.1.1 Global Non-Invasive Prenatal Testing Kit Revenue by Players (2017-2022)
3.1.2 Global Non-Invasive Prenatal Testing Kit Market Share by Players (2017-2022)
3.2 Global Non-Invasive Prenatal Testing Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Non-Invasive Prenatal Testing Kit Revenue
3.4 Global Non-Invasive Prenatal Testing Kit Market Concentration Ratio
3.4.1 Global Non-Invasive Prenatal Testing Kit Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Prenatal Testing Kit Revenue in 2021
3.5 Global Non-Invasive Prenatal Testing Kit Key Players Head office and Area Served
3.6 Key Players Non-Invasive Prenatal Testing Kit Product Solution and Service
3.7 Date of Enter into Non-Invasive Prenatal Testing Kit Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Non-Invasive Prenatal Testing Kit Breakdown Data by Type
4.1 Global Non-Invasive Prenatal Testing Kit Historic Revenue by Type (2017-2022)
4.2 Global Non-Invasive Prenatal Testing Kit Forecasted Revenue by Type (2023-2028)
5 Global Non-Invasive Prenatal Testing Kit Breakdown Data by Application
5.1 Global Non-Invasive Prenatal Testing Kit Historic Market Size by Application (2017-2022)
5.2 Global Non-Invasive Prenatal Testing Kit Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022)
6.2 North America Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2028)
6.3 North America Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2028)
6.4 North America Non-Invasive Prenatal Testing Kit Revenue by Country (2017-2028)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022)
7.2 Europe Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2028)
7.3 Europe Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2028)
7.4 Europe Non-Invasive Prenatal Testing Kit Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022)
8.2 Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2028)
8.3 Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2028)
8.4 Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022)
9.2 Latin America Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2028)
9.3 Latin America Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2028)
9.4 Latin America Non-Invasive Prenatal Testing Kit Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022)
10.2 Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2028)
10.3 Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2028)
10.4 Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Sequenom
11.1.1 Sequenom Company Details
11.1.2 Sequenom Business Overview
11.1.3 Sequenom Non-Invasive Prenatal Testing Kit Products and Services
11.1.4 Sequenom Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022)
11.1.5 Sequenom Non-Invasive Prenatal Testing Kit SWOT Analysis
11.1.6 Sequenom Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Non-Invasive Prenatal Testing Kit Products and Services
11.2.4 Roche Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022)
11.2.5 Roche Non-Invasive Prenatal Testing Kit SWOT Analysis
11.2.6 Roche Recent Developments
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Non-Invasive Prenatal Testing Kit Products and Services
11.3.4 Natera Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022)
11.3.5 Natera Non-Invasive Prenatal Testing Kit SWOT Analysis
11.3.6 Natera Recent Developments
11.4 LabCorp
11.4.1 LabCorp Company Details
11.4.2 LabCorp Business Overview
11.4.3 LabCorp Non-Invasive Prenatal Testing Kit Products and Services
11.4.4 LabCorp Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022)
11.4.5 LabCorp Non-Invasive Prenatal Testing Kit SWOT Analysis
11.4.6 LabCorp Recent Developments
11.5 BGI Genomics
11.5.1 BGI Genomics Company Details
11.5.2 BGI Genomics Business Overview
11.5.3 BGI Genomics Non-Invasive Prenatal Testing Kit Products and Services
11.5.4 BGI Genomics Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022)
11.5.5 BGI Genomics Non-Invasive Prenatal Testing Kit SWOT Analysis
11.5.6 BGI Genomics Recent Developments
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Details
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Kit Products and Services
11.6.4 Quest Diagnostics Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022)
11.6.5 Quest Diagnostics Non-Invasive Prenatal Testing Kit SWOT Analysis
11.6.6 Quest Diagnostics Recent Developments
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Non-Invasive Prenatal Testing Kit Products and Services
11.7.4 Illumina Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022)
11.7.5 Illumina Non-Invasive Prenatal Testing Kit SWOT Analysis
11.7.6 Illumina Recent Developments
11.8 Berry Genomics
11.8.1 Berry Genomics Company Details
11.8.2 Berry Genomics Business Overview
11.8.3 Berry Genomics Non-Invasive Prenatal Testing Kit Products and Services
11.8.4 Berry Genomics Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022)
11.8.5 Berry Genomics Non-Invasive Prenatal Testing Kit SWOT Analysis
11.8.6 Berry Genomics Recent Developments
12 Non-Invasive Prenatal Testing Kit Market Dynamics
12.1 Non-Invasive Prenatal Testing Kit Market Trends
12.2 Non-Invasive Prenatal Testing Kit Market Drivers
12.3 Non-Invasive Prenatal Testing Kit Market Challenges
12.4 Non-Invasive Prenatal Testing Kit Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Non-Invasive Prenatal Testing Kit Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of High & Average Risk
Table 3. Key Players of Low Risk
Table 4. Global Non-Invasive Prenatal Testing Kit Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Non-Invasive Prenatal Testing Kit Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Non-Invasive Prenatal Testing Kit Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Region (2017-2022)
Table 8. Global Non-Invasive Prenatal Testing Kit Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Non-Invasive Prenatal Testing Kit Market Share by Players (2017-2022)
Table 10. Global Top Non-Invasive Prenatal Testing Kit Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing Kit as of 2021)
Table 11. Ranking of Global Top Non-Invasive Prenatal Testing Kit Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Non-Invasive Prenatal Testing Kit Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Non-Invasive Prenatal Testing Kit Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Non-Invasive Prenatal Testing Kit Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Non-Invasive Prenatal Testing Kit Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2017-2022)
Table 19. Global Non-Invasive Prenatal Testing Kit Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2023-2028)
Table 21. Global Non-Invasive Prenatal Testing Kit Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2017-2022)
Table 23. Global Non-Invasive Prenatal Testing Kit Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2023-2028)
Table 25. North America Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Non-Invasive Prenatal Testing Kit Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Non-Invasive Prenatal Testing Kit Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Non-Invasive Prenatal Testing Kit Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Non-Invasive Prenatal Testing Kit Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Non-Invasive Prenatal Testing Kit Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Non-Invasive Prenatal Testing Kit Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Non-Invasive Prenatal Testing Kit Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Non-Invasive Prenatal Testing Kit Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Non-Invasive Prenatal Testing Kit Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Non-Invasive Prenatal Testing Kit Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Non-Invasive Prenatal Testing Kit Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Non-Invasive Prenatal Testing Kit Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue by Country (2023-2028) & (US$ Million)
Table 60. Sequenom Company Details
Table 61. Sequenom Business Overview
Table 62. Sequenom Non-Invasive Prenatal Testing Kit Product and Services
Table 63. Sequenom Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022) & (US$ Million)
Table 64. Sequenom Non-Invasive Prenatal Testing Kit SWOT Analysis
Table 65. Sequenom Recent Developments
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Non-Invasive Prenatal Testing Kit Product and Services
Table 69. Roche Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022) & (US$ Million)
Table 70. Roche Non-Invasive Prenatal Testing Kit SWOT Analysis
Table 71. Roche Recent Developments
Table 72. Natera Company Details
Table 73. Natera Business Overview
Table 74. Natera Non-Invasive Prenatal Testing Kit Product and Services
Table 75. Natera Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022) & (US$ Million)
Table 76. Natera Non-Invasive Prenatal Testing Kit SWOT Analysis
Table 77. Natera Recent Developments
Table 78. LabCorp Company Details
Table 79. LabCorp Business Overview
Table 80. LabCorp Non-Invasive Prenatal Testing Kit Product and Services
Table 81. LabCorp Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022) & (US$ Million)
Table 82. LabCorp Non-Invasive Prenatal Testing Kit SWOT Analysis
Table 83. LabCorp Recent Developments
Table 84. BGI Genomics Company Details
Table 85. BGI Genomics Business Overview
Table 86. BGI Genomics Non-Invasive Prenatal Testing Kit Product and Services
Table 87. BGI Genomics Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022) & (US$ Million)
Table 88. BGI Genomics Non-Invasive Prenatal Testing Kit SWOT Analysis
Table 89. BGI Genomics Recent Developments
Table 90. Quest Diagnostics Company Details
Table 91. Quest Diagnostics Business Overview
Table 92. Quest Diagnostics Non-Invasive Prenatal Testing Kit Product and Services
Table 93. Quest Diagnostics Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022) & (US$ Million)
Table 94. Quest Diagnostics Non-Invasive Prenatal Testing Kit SWOT Analysis
Table 95. Quest Diagnostics Recent Developments
Table 96. Illumina Company Details
Table 97. Illumina Business Overview
Table 98. Illumina Non-Invasive Prenatal Testing Kit Product and Services
Table 99. Illumina Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022) & (US$ Million)
Table 100. Illumina Non-Invasive Prenatal Testing Kit SWOT Analysis
Table 101. Illumina Recent Developments
Table 102. Berry Genomics Company Details
Table 103. Berry Genomics Business Overview
Table 104. Berry Genomics Non-Invasive Prenatal Testing Kit Product and Services
Table 105. Berry Genomics Non-Invasive Prenatal Testing Kit Revenue in Non-Invasive Prenatal Testing Kit Business (2017-2022) & (US$ Million)
Table 106. Berry Genomics Non-Invasive Prenatal Testing Kit SWOT Analysis
Table 107. Berry Genomics Recent Developments
Table 108. Non-Invasive Prenatal Testing Kit Market Trends
Table 109. Non-Invasive Prenatal Testing Kit Market Drivers
Table 110. Non-Invasive Prenatal Testing Kit Market Challenges
Table 111. Non-Invasive Prenatal Testing Kit Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Invasive Prenatal Testing Kit Sales Market Share by Type: 2021 VS 2028
Figure 2. High & Average Risk Features
Figure 3. Low Risk Features
Figure 4. Global Non-Invasive Prenatal Testing Kit Sales Market Share by Application: 2021 VS 2028
Figure 5. 0-12 weeks Case Studies
Figure 6. 13-24 weeks Case Studies
Figure 7. 25-36 weeks Case Studies
Figure 8. Non-Invasive Prenatal Testing Kit Report Years Considered
Figure 9. Global Non-Invasive Prenatal Testing Kit Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Non-Invasive Prenatal Testing Kit Market Size 2017-2028 (US$ Million)
Figure 11. Global Non-Invasive Prenatal Testing Kit Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Non-Invasive Prenatal Testing Kit Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Non-Invasive Prenatal Testing Kit Market Share by Players in 2021
Figure 15. Global Top Non-Invasive Prenatal Testing Kit Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing Kit as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Non-Invasive Prenatal Testing Kit Revenue in 2021
Figure 17. North America Non-Invasive Prenatal Testing Kit Revenue Market Share by Company in 2021
Figure 18. North America Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2017-2028)
Figure 19. North America Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2017-2028)
Figure 20. North America Non-Invasive Prenatal Testing Kit Revenue Share by Country (2017-2028)
Figure 21. United States Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Non-Invasive Prenatal Testing Kit Revenue Market Share by Company in 2021
Figure 24. Europe Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2017-2028)
Figure 25. Europe Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2017-2028)
Figure 26. Europe Non-Invasive Prenatal Testing Kit Revenue Share by Country (2017-2028)
Figure 27. Germany Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 28. France Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 29. U.K. Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 30. Italy Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 31. Russia Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue Market Share by Company in 2021
Figure 33. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2017-2028)
Figure 34. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2017-2028)
Figure 35. Asia Pacific Non-Invasive Prenatal Testing Kit Revenue Share by Region (2017-2028)
Figure 36. China Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 37. Japan Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 38. South Korea Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 39. India Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 40. Australia Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 41. China Taiwan Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 42. Indonesia Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 43. Thailand Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 44. Malaysia Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 45. Latin America Non-Invasive Prenatal Testing Kit Revenue Market Share by Company in 2021
Figure 46. Latin America Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2017-2028)
Figure 47. Latin America Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2017-2028)
Figure 48. Latin America Non-Invasive Prenatal Testing Kit Revenue Share by Country (2017-2028)
Figure 49. Mexico Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 50. Brazil Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 51. Argentina Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue Market Share by Company in 2021
Figure 53. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Non-Invasive Prenatal Testing Kit Revenue Share by Country (2017-2028)
Figure 56. Turkey Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 58. UAE Non-Invasive Prenatal Testing Kit Revenue (2017-2028) & (US$ Million)
Figure 59. Sequenom Revenue Growth Rate in Non-Invasive Prenatal Testing Kit Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Non-Invasive Prenatal Testing Kit Business (2017-2022)
Figure 61. Natera Revenue Growth Rate in Non-Invasive Prenatal Testing Kit Business (2017-2022)
Figure 62. LabCorp Revenue Growth Rate in Non-Invasive Prenatal Testing Kit Business (2017-2022)
Figure 63. BGI Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Kit Business (2017-2022)
Figure 64. Quest Diagnostics Revenue Growth Rate in Non-Invasive Prenatal Testing Kit Business (2017-2022)
Figure 65. Illumina Revenue Growth Rate in Non-Invasive Prenatal Testing Kit Business (2017-2022)
Figure 66. Berry Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Kit Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
  • Global Intravenous Anticoagulants Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 98
    Anticoagulants are medicines that prevent blood clots from forming and stop existing clots from growing bigger. Highlights The global Intravenous Anticoagulants market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Intravenous Anticoagulants is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.......
  • Global Obstetrics and Gynecology Drugs Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 99
    Highlights The global Obstetrics and Gynecology Drugs market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Obstetrics and Gynecology Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Obstetrics and Gynecology Drugs is estimated to increase from $ million in 202......
  • Global Huoxiang Zhengqi for COVID-19 Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 97
    Highlights The global Huoxiang Zhengqi for COVID-19 market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Huoxiang Zhengqi for COVID-19 is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Huoxiang Zhengqi for COVID-19 is estimated to increase from $ million in 2022 to r......
  • Global Non-Insulin Hypoglycemic Drug Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 101
    Highlights The global Non-Insulin Hypoglycemic Drug market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Non-Insulin Hypoglycemic Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Non-Insulin Hypoglycemic Drug is estimated to increase from $ million in 2022 to r......
  • Global Sonidegib Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 69
    It is an oral Hedgehog pathway inhibitor indicated for the treatment of adult patients with locally advanced basal cell carcinoma who are ineligible for surgery or radiation, or who have relapsed after surgery or radiation. Highlights The global Sonidegib market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Sonidegib is estimated to increase from $ million in 2022 to reach $ mil......
  • Global Isolate CBD Oil Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 98
    Highlights The global Isolate CBD Oil market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Isolate CBD Oil is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Isolate CBD Oil is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % dur......
  • 2022-2030 Report on Global Corneal Edema Drugs Market by Player, Region, Type, Application and Sales Channel
    Published: 28-Nov-2022        Price: US 2500 Onwards        Pages: 92
    This report studies the Corneal Edema Drugs market, covering market size for segment by type (Rx Drugs, OTC Drugs, etc.), by application (Hospital & Clinic, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Bausch + Lomb, Abbott, Clear Eyes, Sager Pharma, ALCON, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Corneal Ed......
  • 2022-2030 Report on Global Liquid Biopsy Potential Testing Market by Player, Region, Type, Application and Sales Channel
    Published: 28-Nov-2022        Price: US 2500 Onwards        Pages: 105
    This report studies the Liquid Biopsy Potential Testing market, covering market size for segment by type (CTC, ctDNA, etc.), by application (Food Laboratory, Hospital & Clinic, etc.), by sales channel (Direct Channel, Distribution Channel), by player (RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global mark......
  • 2022-2030 Report on Global Liquid Biopsy Products Market by Player, Region, Type, Application and Sales Channel
    Published: 28-Nov-2022        Price: US 2500 Onwards        Pages: 113
    This report studies the Liquid Biopsy Products market, covering market size for segment by type (CTC, ctDNA, etc.), by application (Food Laboratory, Hospital & Clinic, etc.), by sales channel (Direct Channel, Distribution Channel), by player (RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Li......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs